PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 114 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $201,000 | +16.2% | 40,198 | +64.3% | 0.00% | – |
Q1 2021 | $173,000 | -78.1% | 24,460 | -80.6% | 0.00% | -100.0% |
Q4 2020 | $790,000 | -0.8% | 126,208 | -21.0% | 0.00% | 0.0% |
Q3 2020 | $796,000 | +325.7% | 159,762 | +345.0% | 0.00% | – |
Q2 2020 | $187,000 | +61.2% | 35,898 | -2.8% | 0.00% | – |
Q1 2020 | $116,000 | -38.0% | 36,948 | -20.3% | 0.00% | – |
Q4 2019 | $187,000 | -25.8% | 46,348 | -20.5% | 0.00% | – |
Q3 2019 | $252,000 | -25.0% | 58,323 | -30.7% | 0.00% | – |
Q2 2019 | $336,000 | -30.3% | 84,123 | -6.4% | 0.00% | -100.0% |
Q1 2019 | $482,000 | -4.6% | 89,865 | -8.8% | 0.00% | 0.0% |
Q4 2018 | $505,000 | -47.2% | 98,528 | -0.1% | 0.00% | 0.0% |
Q3 2018 | $957,000 | +6.0% | 98,675 | +11.4% | 0.00% | -50.0% |
Q2 2018 | $903,000 | -21.5% | 88,573 | +0.1% | 0.00% | 0.0% |
Q1 2018 | $1,150,000 | +166.2% | 88,494 | +266.3% | 0.00% | +100.0% |
Q4 2017 | $432,000 | +49.5% | 24,157 | +109.6% | 0.00% | 0.0% |
Q3 2017 | $289,000 | – | 11,525 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 2,138,872 | $55,119,000 | 27.83% |
Abingworth LLP | 1,301,413 | $33,524,000 | 15.22% |
Roumell Asset Management, LLC | 207,703 | $5,353,000 | 9.43% |
GREAT POINT PARTNERS LLC | 415,338 | $10,703,000 | 4.17% |
Aisling Capital LLC | 682,680 | $17,593,000 | 2.62% |
Broadfin Capital, LLC | 530,283 | $13,665,000 | 0.73% |
Baupost Group | 1,544,498 | $39,802,000 | 0.66% |
Tekla Capital Management LLC | 691,000 | $17,807,000 | 0.64% |
GENERAL AMERICAN INVESTORS CO INC | 277,076 | $7,140,000 | 0.59% |
Lombard Odier Asset Management (USA) Corp | 140,000 | $3,607,000 | 0.26% |